The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Novel Approaches to Drug Discovery for Parkinson's Disease, 2009Cerium Oxide Nanoparticles in Treatment of Parkinson's Disease
Objective/Rationale:
Nanotechnology and nanomedicine hold potential to advance medical treatment through construction of materials with enhanced biological effects, at the atomic scale. By... -
Novel Approaches to Drug Discovery for Parkinson's Disease, 2009Novel JNK Inhibitors as Therapeutic Agents for Parkinson's Disease
Objective/Rationale:
Our objective is to test the in vivo pharmacokinetic profile, mode of action and efficacy of two novel and highly selective JNK inhibitors in the MPTP (1-methyl-4-phenyl-1,2,3,6... -
Program-non-specific Funding, 2009LRRK2 Variation in Parkinson's Disease
Objective/Rationale:
Over the last decade genetic causes of Parkinson’s disease have given great insights into the pathways and mechanisms that play a role in the disease. The discovery of common... -
Program-non-specific Funding, 2009Delivery of Kinase-Modified LRRK2 to Dopaminergic Neurons Using High-Capacity Viral Vectors
Promising Outcomes of Original Grant:
Mutations in LRRK2 are the most common known cause of PD, and LRRK2 demonstrates kinase-dependent neurotoxicity in vitro but these results have not been confirmed... -
Program-non-specific Funding, 2009Immunology and bio activity of regulated rAAV1-GDNF in pre-clinical models of PD
Objective/Rationale:
Clinical trials with a trophic factor called GDNF, where GDNF is injected directly in the brain by pumps, have not been completely successful. Many scientists believe that the... -
Program-non-specific Funding, 2009Time Course of TNF-alpha Expression and Oxidative Stress after Intrastriatal 6-OHDA
Objective/Rationale:
Animal models of Parkinson’s disease can provide investigators with tools to examine the causes of the disease itself as well as potential therapies for treatment. One of the most...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.